Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Non-Small Cell Lung Cancer
Both
Non-Small Cell Lung Cancer
Trial Information
Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Non-squamous non-small cell lung cancer (NSCLC) treated with first-line Avastin-based
therapy
- Progression-free survival of >/= 9 months reached
Exclusion Criteria:
- N/A
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Progression-free survival (>9 months) according to clinical phenotype
Outcome Time Frame:
approximately 9 months
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Spain: Agencia Española de Medicamentos y productos sanitarios (AEMPyS)
Study ID:
ML25494
NCT ID:
NCT01343914
Start Date:
June 2011
Completion Date:
December 2011
Related Keywords:
- Non-Small Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
